Target Information

NEXTBLUE Fund II has recently announced its investment in DAYA, a venture studio and accelerator based in Sweden that specializes in deep tech and women's health. DAYA focuses on developing solutions that address the pain points faced by existing medical institutions and patients by partnering with hospitals and universities in Sweden. The firm identifies specific issues and leverages its extensive network to support founders throughout the startup process, from prototype design to recruitment of founding teams and fundraising.

DAYA is currently creating startups with entrepreneurs who possess promising but untested ideas. The firm emphasizes building solutions based on thorough market research and unique insights, with a goal of launching five startups annually across various fields, including biotechnology, digital health, and medical technology. Their approach to women's health encompasses not only traditionally recognized areas like physiological femtech but also

View Original Article